References

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2021 · External reference

Unresolved reference

External reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

10.1002/(sici)1096-9896(199909)189:1<12::aid-path431>3.0.co;2-f · 1999 · External reference

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

10.1016/s2214-109x(19)30482-6 · 2020 · External reference

Unresolved reference

2020 · External reference

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

10.1016/s0140-6736(13)62218-7 · 2014 · External reference

Unresolved reference

2024 · External reference

Unresolved reference

2023 · External reference

Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening

10.1186/s13027-020-00328-1 · 2020 · External reference

Evaluation of an isothermal amplification HPV assay on self-collected vaginal samples as compared to clinician-collected cervical samples

10.3390/diagnostics13213297 · 2023 · External reference

Unresolved reference

2021 · External reference

Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study

10.3802/jgo.2024.35.e6 · 2024 · External reference

Unresolved reference

2024 · External reference

Determining the prevalence of high-risk human papillomavirus infection using a novel cervical precancer screening approach in incarcerated women at the Nsawam Medium Security Prison, Ghana

10.3332/ecancer.2021.1248 · 2021 · External reference

Improved cervical screening using HPV type restriction and cycle threshold limit setting with the AmpFire assay: a prospective screening cohort of women with and without HIV in Botswana

10.1002/ijgo.70074 · 2025 · External reference

Feasibility and acceptability of an HPV self-testing strategy: lessons from a research context to assess for ability to implement into primary care at a national level in Botswana

10.3389/fgwh.2023.1300788 · 2024 · External reference

10.1186/s41073-019-0064-8 · 2019 · Admitted local publication

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

10.7326/m18-0850 · 2018 · External reference

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

2000 · External reference

AmpFire HPV and ScreenFire RS HPV validation trial

10.1093/ajcp/aqad181 · 2024 · External reference

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

10.1186/s13027-023-00504-z · 2023 · External reference

Design of the HPV-Automated Visual Evaluation (PAVE) study: validating a novel cervical screening strategy

2024 · External reference

Analytical performance of the ScreenFire HPV RS Zebra BioDome assay on four different qPCR platforms

10.1186/s13027-025-00651-5 · 2025 · External reference

Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi

10.1186/s13027-024-00585-4 · 2024 · External reference

A rapid HPV typing assay to support global cervical cancer screening and risk-based management: a cross-sectional study

10.1002/ijc.34698 · 2024 · External reference

SCALE: single visit clinical validation of ScreenFire, a low-cost HPV test - efficacy and cost effectiveness

2026 · External reference

One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique

10.1038/s41467-025-62454-x · 2025 · External reference

Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review

10.1186/s12905-022-02043-y · 2022 · External reference

Public health concern-driven insights and response of low- and middle-income nations to the World Health Organization call for cervical cancer risk eradication

2024 · External reference

Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis

10.1136/bmjgh-2018-001351 · 2019 · External reference

Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: experience from Battor, Ghana

10.1371/journal.pgph.0001639 · 2023 · External reference

Self-collection for primary HPV screening using dry swabs: a review of clinical performance, laboratory considerations, and patient preferences

2025 · External reference

Coverage and Socioeconomic Inequalities in Cervical Cancer Screening in Low- and Middle-Income Countries Between 2010 and 2019

10.1200/go.23.00385 · 2024 · External reference

Evaluation of liquid versus dry specimen transport with a newly validated isothermal amplification high-risk HPV assay

10.1097/lgt.0000000000000546 · 2020 · External reference

Advances in technologies for cervical cancer detection in low-resource settings

10.1080/14737159.2019.1648213 · 2019 · External reference

Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer Screening

10.3390/v16121852 · 2024 · External reference

Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries

10.1136/bmjopen-2022-065074 · 2023 · External reference

A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing

10.1186/s13027-020-00329-0 · 2020 · External reference

Comparison of high-risk HPV detection by the AmpFire® HPV Screening 16/18/HR technique (Atila Biosystems) and the hybrid capture 2 test (Qiagen)

10.1007/s11033-023-08939-8 · 2024 · External reference

Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda

10.4102/ajlm.v11i1.1827 · 2022 · External reference

The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador

2019 · External reference

Cervical cancer screening among incarcerated women

2018 · External reference

An isothermal, multiplex amplification assay for detection and genotyping of human papillomaviruses in formalin-fixed, paraffin-embedded tissues

10.1016/j.jmoldx.2019.12.004 · 2020 · External reference

Triage of HPV positivity in a high HIV prevalence setting: a prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana

10.1002/ijgo.15225 · 2024 · External reference

Collaboration on Self-Sampling and HPV Testing. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

10.1136/bmj.k4823 · 2018 · External reference

A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities

10.3389/fpubh.2021.670032 · 2021 · External reference

Interventions to close the gap for cervical cancer elimination: a global strategy

2022 · External reference

Estimates of the global burden of cervical cancer associated with HIV

10.1016/s2214-109x(20)30459-9 · 2021 · External reference

Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: a systematic review and meta-analysis

10.1016/j.ygyno.2022.06.012 · 2022 · External reference

Acceptability of home-based HPV self-sampling for cervical cancer screening among users and providers in the West region of Cameroon: a cross-sectional study

10.1186/s12913-025-13467-1 · 2025 · External reference

Improving healthcare for incarcerated women

2010 · External reference